Dopamine Receptor d1 Antikörper (C-Term)
Kurzübersicht für Dopamine Receptor d1 Antikörper (C-Term) (ABIN363247)
Target
Alle Dopamine Receptor d1 (DRD1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Reacts with mouse and rat Dopamine Receptor D1A
-
Kreuzreaktivität
- Kaninchen, Schaf
-
Kreuzreaktivität (Details)
- Do not react with human, dog, pig, sheep, rabbit, or cow proteins. Do not cross react with D1B (D5) receptor.
-
Aufreinigung
- Purified (protein A)
-
Immunogen
- Recombinant rat D1 (D1A) dopamine receptor (123 residues with 23 residues near the C-terminus)
-
Isotyp
- IgG2b kappa
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- ICC : 2 μg/mL - IF : 2 μg/mL - WB : 2 μg/mL -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.4 mg/mL
-
Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide 0.05 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C/-80 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
-
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Andere Bezeichnung
- Dopamine D1 Receptor
-
Pathways
- cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Target
-